Tag: FluidX medical
Fluidx Medical announces first patient treated in prospective trial
Fluidx Medical has announced that the first patient has been treated in the GPX investigational device exception (IDE) prospective multinational clinical trial.
The GPX...
Fluidx Medical announces US FDA approval for embolic device clinical trial
Fluidx Medical Technology has announced that the US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) approval to initiate the GPX...
Interventional News’ top 10 most popular stories of November 2023
In November, the most popular stories from Interventional News included stories from our latest issue concerning the global lack of interventional radiology (IR) devices...
Fluidx Medical launches new embolic platform for tumour treatment
Fluidx Medical has released information about their new ULTRA embolic platform designed to make therapeutic embolization procedures safer, better, and faster, as the recent...
Fluidx Medical unveils new embolic for neurovascular use
Fluidx Medical has released information regarding the success of the IMPASS Embolic Device in in vivo research related to middle meningeal artery (MMA) embolizations...
Metastatic tumour treatment with novel GPX embolic device
An embolic device by Fluidx Medical has been used successfully in a variety of complex cancer cases, according to a company press release.
As part...
Fluidx Medical’s embolic device demonstrates promising visibility
Fluidx Medical Technology has announced the results of the GPX-Clear embolic device in-vivo research which uses the base GPX technology and incorporates an intermediate-term...
Fluidx Medical reports successful use of GPX embolic device in challenging...
Fluidx Medical recently announced that its GPX embolic device was used to effectively devascularise a large tumour with multiple feeding vessels as part of...
Fluidx Medical Technology announces Series A led by multinational strategic investor
Fluidx Medical Technology, has recently announced the oversubscribed closing of the first tranche of the Series A financing round. The Series A was led...
Innovative embolic device shows promise for interventional oncology drug delivery
Fluidx Medical’s GPX embolic device has released initial results for Oncology Drug Delivery. Fluidx Medical Technology announced that a next-generation, doxorubicin-loaded GPX embolic device...
New embolic device blocks vessels feeding malignant tumours
Fluidx Medical have released details on the clinical use of their GPX embolic device, demonstrating its ability to block flow to small microvasculature and...
New proprietary gel-coated biocompatible embolic, GPX, presented at LINC
Two scientific abstracts of a new vascular embolic device, GPX (Fluidx Medical Technology) were presented this week at the 2018 Leipzig Interventional Congress (LINC;...
